c
h
p
e
r
acut
exacerb
chronic
obstruct
pulmonari
diseas
k
e
p
n
chronic
obstruct
pulmonari
diseas
copd
refer
fix
airflow
obstruct
caus
chronic
bronchiti
product
cough
least
month
year
least
consecut
year
emphysema
destruct
alveoli
tobacco
smoke
account
almost
case
copd
includ
viral
upper
respiratori
tract
infect
bacteri
infect
commonli
streptococcu
pneumonia
haemophilu
influenza
moraxella
catarrhali
pollut
heart
failur
pulmonari
embol
medic
betablock
narcot
sed
univers
accept
definit
acut
exacerb
copd
commonli
use
definit
worsen
dyspnea
increas
sputum
purul
increas
sputum
volum
patient
copd
symptom
sign
copd
exacerb
includ
wheez
distant
breath
sound
tachypnea
tachycardia
accessori
muscl
use
cyanosi
agit
confus
stupor
initi
test
includ
puls
oximetri
chest
xray
electrocardiogram
possibl
test
includ
arteri
blood
ga
patient
distress
somnol
rais
concern
acut
respiratori
acidosi
sputum
gram
stain
cultur
appropri
patient
fail
respond
empir
therapi
administ
supplement
oxygen
hypoxemia
goal
oxygen
satur
correspond
partial
pressur
arteri
oxygen
mmhg
higher
oxygen
satur
may
caus
hypercarbia
reduc
respiratori
drive
promot
ventilationperfus
mismatch
betaagonist
anticholinerg
agent
equal
efficaci
improv
airflow
copd
exacerb
combin
therapi
typic
use
clinic
practic
appear
confer
substanti
benefit
monotherapi
either
agent
alon
role
aminophyllin
methylxanthin
bronchodil
set
copd
exacerb
controversi
medic
uncertain
efficaci
potenti
toxic
system
glucocorticoid
improv
fev
reduc
treatment
failur
rate
length
hospit
copd
exacerb
optim
dose
rout
durat
therapi
unknown
patient
sever
copd
exacerb
one
like
benefit
antibiot
although
effect
antibiot
durat
sever
exacerb
appear
minim
definit
data
regard
optim
durat
therapi
mucolyt
agent
mechan
chest
percuss
probabl
benefici
patient
copd
exacerb
tobacco
smoke
account
almost
case
copd
cigarett
smoke
increas
number
neutrophil
macrophag
airway
cell
releas
proteas
enzym
degrad
protein
destroy
lung
parenchyma
individu
unabl
mount
adequ
antiproteas
respons
result
mucu
product
increas
airway
becom
narrow
lose
support
structur
develop
increas
collaps
lead
airway
obstruct
acut
exacerb
copd
inflamm
bronchospasm
mucu
hypersecret
lead
airway
narrow
worsen
ventilationperfus
vq
mismatch
hypoxemia
work
breath
increas
overcom
high
airway
resist
lead
increas
oxygen
consumpt
respiratori
muscl
lower
oxygen
content
venou
blood
copd
exacerb
becom
frequent
increas
diseas
sever
import
trigger
exacerb
viral
upper
respiratori
tract
infect
especi
rhinoviru
caus
airway
inflamm
oxid
stress
box
although
bacteria
often
cultur
patient
acut
copd
exacerb
unclear
whether
organ
pathogen
colon
bacteria
also
cultur
mani
patient
stabl
copd
common
pathogen
bacteria
streptococcu
pneumonia
haemophilu
influenza
moraxella
catarrhali
copd
exacerb
common
winter
acut
exacerb
copd
upper
respiratori
tract
infect
common
month
cold
temperatur
caus
small
reduct
lung
function
exacerb
also
link
increas
environment
pollut
thought
increas
suscept
viral
respiratori
infect
precipit
copd
exacerb
includ
heart
failur
pulmonari
embol
medic
betablock
may
caus
bronchospasm
worsen
ventilationperfus
mismatch
narcot
sed
may
reduc
ventilatori
drive
lead
hypercarbia
acidosi
respiratori
failur
univers
accept
definit
acut
exacerb
copd
commonli
use
definit
use
consist
rigor
clinic
trial
combin
follow
three
clinic
find
patient
establish
copd
worsen
dyspnea
increas
sputum
purul
increas
sputum
volum
hypoxemia
hypercarbia
often
present
mild
copd
exacerb
may
present
minim
sign
wheez
auscult
sever
copd
worsen
breath
sound
may
distant
may
sign
hypoxemia
includ
cyanosi
tachypnea
agit
tachycardia
accessori
muscl
use
may
occur
increas
work
breath
inward
abdomin
motion
inspir
abdomin
paradox
sign
impend
diaphragmat
muscl
fatigu
worsen
acut
exacerb
copd
respiratori
failur
patient
becom
increasingli
hypercarb
acidem
lead
confus
stupor
ultim
apnea
initi
laboratori
test
includ
puls
oximetri
monitor
level
hypoxemia
classic
find
copd
includ
hyperinfl
lung
flatten
diaphragm
narrow
lengthen
mediastinum
chest
xray
obtain
patient
present
copd
exacerb
find
radiographi
shown
chang
shortterm
manag
mani
patient
new
pulmonari
infiltr
evid
heart
failur
copd
exacerb
requir
abg
measur
abg
analysi
appropri
patient
distress
somnol
rais
concern
acut
respiratori
acidosi
abg
never
delay
intub
patient
stabl
copd
may
chronic
respiratori
acidosi
longstand
carbon
dioxid
retent
result
airway
obstruct
abg
analysi
patient
show
increas
partial
pressur
arteri
carbon
dioxid
paco
normal
arteri
ph
kidney
buffer
acid
retain
bicarbon
patient
superimpos
acut
respiratori
acidosi
reduc
arteri
ph
higher
paco
compar
baselin
measur
kidney
unabl
buffer
acid
result
acut
carbon
dioxid
retent
admiss
ecg
recommend
rule
cardiac
condit
ischemia
acut
myocardi
infarct
may
contribut
copd
exacerb
continu
cardiac
monitor
appropri
patient
moder
sever
copd
exacerb
patient
signific
histori
coronari
arteri
diseas
patient
known
cardiac
arrhythmia
multifoc
atrial
tachycardia
atrial
fibril
white
sputum
may
suggest
nonbacteri
caus
copd
exacerb
wherea
green
sputum
may
suggest
bacteri
infect
howev
sputum
sampl
notori
unreli
distinguish
infect
colon
oropharyng
contamin
therefor
sputum
gram
stain
cultur
reserv
patient
respond
empir
therapi
spirometri
recommend
copd
exacerb
techniqu
provid
reliabl
measur
diseas
sever
use
guid
therapi
tabl
fig
supplement
oxygen
appropri
copd
exacerb
accompani
hypoxemia
oxygen
satur
maintain
correspond
partial
pressur
arteri
oxygen
pao
mm
hg
acut
exacerb
copd
target
ensur
nearmaxim
hemoglobin
satur
higher
oxygen
satur
may
caus
hypercarbia
reduc
respiratori
drive
promot
ventilationperfus
mismatch
patient
present
emerg
depart
requir
hospit
admiss
chest
xray
arteri
blood
gasif
concern
acut
respiratori
acidosi
somnol
distress
supplement
oxygengo
satur
bronchodil
via
nebul
patient
toler
metereddos
inhal
albuterol
mg
vial
ipratropium
bromid
mg
vial
nebul
least
everi
hour
albuterol
ipratropium
bromid
puff
inhal
least
everi
hour
glucocorticoid
exampl
methylprednison
mg
iv
everi
hour
x
day
mg
po
daili
x
day
mg
po
daili
x
day
mg
po
daili
x
day
antibiot
exampl
amoxicillin
mg
four
time
daili
day
doxycyclin
mg
day
mg
daili
day
trimethoprimsulfamethoxazol
mg
twice
daili
day
azithromycin
mg
day
mg
day
levofloxacin
mg
daili
day
figur
initi
treatment
acut
exacerb
chronic
obstruct
pulmonari
diseas
requir
hospit
combin
therapi
typic
use
clinic
practic
appear
confer
substanti
benefit
monotherapi
either
agent
alon
acut
exacerb
copd
sever
method
deliv
supplement
oxygen
nasal
cannula
provid
l
oxygen
per
minut
although
actual
percentag
oxygen
inspir
depend
factor
mouthbreath
concentr
oxygen
room
air
gener
rule
thumb
everi
l
oxygen
deliv
per
minut
via
nasal
cannula
inspir
fraction
oxygen
increas
maximum
oxygen
deliveri
via
nasal
cannula
approxim
nonrebreath
face
mask
provid
tighter
control
inspir
oxygen
nasal
cannula
partial
nonrebreath
mask
reservoir
typic
deliv
inspir
oxygen
reservoir
bag
fill
oxygen
empti
inspir
exhal
fill
reservoir
first
portion
expir
ga
contain
high
oxygen
concentr
deriv
dead
space
upper
airway
true
nonrebreath
mask
contain
two
type
valv
deliv
close
oxygen
one
valv
prevent
exhal
ga
enter
reservoir
bag
second
type
valv
permit
exhal
prevent
ambient
air
enter
inhal
circuit
beta
agonist
albuterol
anticholinerg
agent
ipratropium
bromid
bronchodil
equal
effect
improv
airflow
copd
exacerb
medic
commonli
use
togeth
although
combin
therapi
appear
confer
substanti
benefit
monotherapi
either
agent
alon
metereddos
inhal
mdi
nebul
appear
achiev
equival
bronchodil
mdi
cost
less
aminophyllin
methylxanthin
bronchodil
unclear
efficaci
potenti
toxic
therefor
role
medic
set
copd
exacerb
unclear
glucocorticoid
sever
good
qualiti
random
trial
shown
system
glucocorticoid
benefici
acut
copd
exacerb
system
glucocorticoid
improv
fev
reduc
treatment
failur
rate
length
hospit
shortest
use
durat
therapi
unknown
appear
addit
advantag
glucocorticoid
given
week
oral
parenter
glucocorticoid
appear
similar
efficaci
improv
outcom
demonstr
dose
rang
mg
oral
prednison
daili
outpati
emerg
depart
set
mg
intraven
methylprednison
everi
hour
day
follow
mg
oral
prednison
daili
day
gradual
taper
dose
discontinu
day
hospit
patient
howev
optim
dose
rout
durat
therapi
unknown
vari
among
physician
patient
hyperglycemia
import
side
effect
shortterm
glucocorticoid
treatment
patient
frequent
exacerb
may
also
experi
bone
loss
repeat
cours
glucocorticoid
infect
unlik
shortterm
treatment
bacteri
infect
may
contribut
acut
copd
exacerb
sever
random
trial
shown
patient
sever
copd
exacerb
like
benefit
antibiot
although
effect
antibiot
durat
sever
exacerb
appear
minim
trial
commonli
prescrib
tetracyclin
amoxicillin
trimethoprimsulfamethoxazol
day
cover
three
common
causal
pathogen
pneumonia
catarrhali
h
influenza
nowaday
broadspectrum
antibiot
levofloxacin
commonli
use
clinic
practic
emerg
antibiot
resist
especi
among
pneumonia
superior
newer
broaderspectrum
antibiot
establish
also
definit
data
regard
optim
durat
therapi
physician
prescrib
antibiot
day
sever
studi
shown
benefici
effect
mucolyt
agent
mechan
chest
percuss
patient
copd
exacerb
nppv
unload
fatigu
ventilatori
muscl
reduc
rate
intub
inhospit
mortal
durat
hospit
nppv
appropri
copd
patient
acut
respiratori
acidosi
worsen
dyspnea
oxygen
provid
patient
cooper
hemodynam
stabl
excess
secret
abl
protect
airway
patient
toler
nppv
worsen
oxygen
acidemia
intub
patient
readi
hospit
discharg
signific
clinic
improv
occur
use
question
ask
patient
whether
clinic
statu
close
baselin
bronchospasm
minim
absent
oxygen
satur
ambul
fall
patient
persist
hypoxemia
acut
exacerb
copd
despit
resolut
symptom
discharg
supplement
oxygen
via
nasal
cannula
mani
patient
use
mdi
correctli
patient
may
experi
difficulti
coordin
inhal
releas
medic
canist
therefor
recommend
spacer
patient
especi
inhal
glucocorticoid
prescrib
box
followup
clinic
visit
smoke
cessat
discuss
conjug
pneumococc
vaccin
influenza
vaccin
administ
patient
due
vaccin
spirometri
severalweek
trial
inhal
glucocorticoid
use
assess
whether
patient
copd
revers
compon
ie
whether
patient
benefit
longterm
glucocorticoid
patient
shake
inhal
attach
spacer
breath
form
seal
around
mouthpiec
spacer
depress
canist
breath
slowli
mouth
hold
breath
second
long
possibl
wait
minut
repeat
step
applic
rins
mouth
use
inhal
glucocorticoid
reduc
risk
oral
candidiasi
acut
exacerb
copd
